Recent news on Vigabatrin

Toddler gets help from dad's co-workers  -  May 22, 2007
Wilson Daily Times (subscription),Vigabatrin is not FDA approved in the United States. It is awaiting approval here. Wooten told Kim and Greg the pros and cons of the medicine.

Catalyst Pharmaceutical Partners Reports First Quarter 2007 ...  -  May 15, 2007
PharmaLive.com (press release),Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents pending in more than 30 countries.

New Medication Strategies for Comorbid Substance Use and Bipolar ...  -  May 18, 2007
Focus (subscription)With regard to SUD, the irreversible inhibitor of GABA transaminase, -vinyl-GABA (vigabatrin), attenuates cocaine-induced DA release, conditioned place

Severe Adverse Effects Not Increased With Adrenocorticotropic ...  -  May 2, 2007
DG NewsOverall, 43 patients with infantile spasms in this series received ACTH as initial treatment, 16 received vigabatrin, 6 received prednisone, and 11 received

Catalyst Pharmaceutical Partners Reports Year-End 2006 Financial ...  -  Apr 3, 2007
PharmaLive.com (press release),Catalyst has also been granted rights to Brookhaven's vigabatrin-related foreign patents or patents pending in more than 30 countries.

Catalyst Pharmaceutical Partners Reports Year-End 2006 Financial ...  -  Apr 2, 2007
Earthtimes.org...trademark of Sanofi-Aventis), which could provide data potentially linking CPP-109 to the extensive body of published clinical literature on vigabatrin.

Ovation hopes to reduce addictions  -  Feb 12, 2007
Chicago Sun-Times,The company has signed a five-year agreement with the National Institute on Drug Abuse to study its epilepsy drug vigabatrin to treat cocaine and

Dulling dopamine's kick  -  Feb 16, 2007
Newsday,Through research with animals and study of volunteers, he helped discover that a drug called vigabatrin can increase GABA levels and thus keep dopamine from

Catalyst Pharmaceutical Partners, Inc. Strengthens Scientific ...  -  Feb 16, 2007
Drug Newswire (press release),The Company's initial product candidate is CPP-109, which is based on the compound gamma-vinyl-GABA, commonly referred to as vigabatrin.

Catalyst focuses on drug to treat addicts  -  Jan 14, 2007
Miami Herald,Catalyst is a young Coral Gables drug company with a veteran industry chief executive who is betting everything on vigabatrin, an interesting drug with a

Catalyst Pharmaceutical Partners Provides An Update On Its ...  -  Jan 5, 2007
Medical News Today (press release),In the Prospectus, the Company reported that in order to further the available research on the use of vigabatrin to treat cocaine addiction, it intended to

Catalyst Pharmaceutical Partners Provides an Update on its ...  -  Jan 3, 2007
PR Newswire (press release),The Company's initial product candidate is CPP-109, which is based on the compound gamma-vinyl-GABA, commonly referred to as vigabatrin.

Catalyst Pharma trial delayed, stock off  -  Jan 3, 2007
ReutersThe company is studying the chemical used in a drug already approved outside the United States for epilepsy called vigabatrin.

Vigabatrin Appears to Prevent Multiple Forms of Infantile Spasms ...  -  Dec 6, 2006
DG NewsSAN DIEGO, CA -- December 6, 2006 -- Infantile spasms, one of the forms of catastrophic epilepsy, appear to be controlled by treatment with vigabatrin,

Epilepsy pipeline dazzles  -  Dec 4, 2006
Monsters and Critics.com,Vigabatrin, a drug available in most of the world, being developed by Ovation Pharmaceuticals. In a study presented at the conference, researchers led by

Catalyst Pharmaceutical Partners, Inc. Announces Results of ...  -  Dec 17, 2006
Drug Newswire (press release),The Company's initial product candidate is CPP-109, which is based on the chemical compound gamma-vinyl-GABA, commonly referred to as vigabatrin.

No Weight Gain Seen in Patients on Investigative Antiepileptic ...  -  Dec 6, 2006
DG NewsSeveral antiepileptic drugs are known to be associated with weight gain, including valproate, carbamazepine, gabapentin, vigabatrin and pregabalin.

Phase II Data Shows Ovation's Novel Compound Clobazam To Be Well ...  -  Dec 5, 2006
PipelineReview.com (press release),It follows vigabatrin, another novel epilepsy treatment being evaluated for refractory complex partial seizures and infantile spasms.

Biotech Has Lackluster Month of November  -  Dec 1, 2006
PR Newswire (press release),It intends to use the net proceeds to seek approval to commercialize CPP-109, its product candidate based on vigabatrin, to treat cocaine addiction.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional